KENNETH DAWES: Open Payments
NPI 1497758627 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,419 in 143 payments from 20 companies in 2025. Trend: 2023 $2,534 · 2024 $9,334 · 2025 $18,419
Speaker / faculty: $14,075Food & beverage: $2,486Travel & lodging: $1,065Consulting: $720Education: $72
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 33 | $16,570 |
| ABBVIE INC. | 25 | $355 |
| Novartis Pharmaceuticals Corporation | 26 | $267 |
| Arcutis Biotherapeutics, Inc. | 4 | $163 |
| Regeneron Healthcare Solutions, Inc. | 3 | $158 |
| Amgen Inc. | 14 | $148 |
| Lilly USA, LLC | 5 | $107 |
| Janssen Biotech, Inc. | 3 | $99 |
| UCB, Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
Products named: LITFULO, CIBINQO, SKYRIZI, COSENTYX, Zoryve, LIBTAYO, Otezla, RINVOQ.
Industry payments across IN — which companies pay providers there.
